Please login to the form below

Not currently logged in
Email:
Password:

Serge Bernasconi appointed CEO of Eucomed and EDMA ahead of alliance

Joins from Medtronic to lead trade bodies’ efforts to speak as “one voice”

Serge Bernasconi - Eucomed EDMASerge Bernasconi (pictured) is to become the first CEO of both Eucomed and the European Diagnostic Manufacturers Association (EDMA) as the two trade organisations attempt to combine efforts under an alliance.

Former Medtronic VP, Bernasconi, will take over from interim Eucomed CEO Luciano Cattani and EDMA CEO Volker Oeding on July 16, 2012, leading efforts from both groups to speak with “one voice” to address issues of mutual interest.

“The time is right to further intensify the cooperation between Eucomed and EDMA,” Eucomed chair Dr Guy Lebeau. “With his experience and strengths, Serge brings a unique mix of skills to the table which make him uniquely positioned to oversee this process and continue the successful journey both associations have taken.”

Bernasconi has more than 30 years' experience in both the pharmaceutical and medical device industries, serving most recently as president and international regional VP of Medtronic France.

During this time, he gained understanding as an industry representative having been elected president of the French Association for the Promotion of Innovation in Medical Devices (APIDIM), and VP and treasurer of French Medical Technology Industry Association (SNITEM).

In addition, he has worked at Johnson & Johnson (J&J) and Schering Plough in both the US and Europe.

Bernasconi said: “I am excited to become part of a team committed to driving value-based innovation in the industry and as such contributing to more sustainable healthcare systems. I am convinced that both associations occupy an excellent position to help in advancing healthcare in Europe.”

11th July 2012

Share

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
CACTUS

Founded in 2002, Cactus Communications is a fully integrated, global scholarly communications company with offices in Japan, South Korea, India,...

Latest intelligence

Why heading online for scientific meetings can yield greater HCP engagement
Modern conferencing methods, with enhanced digital information transfers, offer unique opportunities for greater HCP engagement....
The threat of antimicrobial resistance
Why this issue is such a fundamental challenge...
Meet the CEO behind ReNeuron’s cutting-edge stem cell therapies
Blue Latitude Health speaks to Olav Hellebo, CEO of ReNeuron, to find out about the biotech’s latest innovation in stem cell therapy and to learn his perspective on navigating the...

Infographics